19.10.2016 • NewsElaine BurridgeHaldor TopsoeCB&I

CB&I and Haldor Topsoe Partner on Syngas

US engineering contractor CB&I has signed an agreement for a long-term alliance on syngas with Danish catalysis and process technology company Haldor Topsoe. Under the deal, CB&I will promote Haldor Topsoe’s syngas-based technologies, which the US-firm said complements its existing portfolio. The alliance adds eight Haldor Topsoe process technologies to CB&I’s current offering of more than 90 technologies and 3,500 patents, while also allowing the US firm to capitalize on the Lyngby-headquartered company’s expertise in engineering, procurement and construction (EPC).

CB&I will also work with Haldor Topsoe on providing EPC services to plants in North America. Patrick Mullen, CB&I’s chief operating officer, said the alliance gives it additional competitive offerings to the industry, adding that the two companies have a long history of technology collaboration. Both companies are working together on a refinery upgrade for Pertamina in Indonesia. The project at Pertamina’s Unit V refinery in Balikpapan, East Kalimantan, will use CB&I’s CDAlky advanced sulfuric acid alkylation process and Haldor Topsoe’s wet gas sulfuric acid technology.

CDAlky is an environmentally friendly alternative route to obtain high-octane premium gasoline that eliminates the need for human contact with sulfuric acid.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.